Angela Eni

Dr. Angela Eni

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2019 in Annals of Global Health
Verified
Journal Article
Open access
PDF file
AEAngela Eni
Angela Eni
MSMojisola G. Soluade
Mojisola G. Soluade
OOOyewumi O. Oshamika
Oyewumi O. Oshamika
OEOghenevwairhe Pretty Efekemo
Oghenevwairhe Pretty Efekemo
TITitilayo T. Igwe
Titilayo T. Igwe
Olabode Azeez Onile-ereOlabode Azeez Onile-ere
Olabode Azeez Onile-ere
The World Health Organisation recently launched a campaign to reduce Hepatitis B Viral Infections by 80% globally. Achieving this goal is partly predicated on proper awareness of persons in regions of high transmission. The aim of this study was to assess the Hepatitis B Virus (HBV) infection knowledge status of persons across three states in Nigeria. A descriptive cross-sectional study among 758 persons selected by convenience sampling was conducted from March to July 2016. Structured questionnaires were administered to consenting participants and analysed using descriptive and inferential statistical methods in SPSS V20. Respondents showed average knowledge with a mean knowledge score of 4.85 ± 2.69 out of a max score of 9.00. Respondents belonging to the working class had significantly better knowledge (5.59 ± 2.34 p < 0.001) than respondents in other categories. High-risk behaviour such as having multiple partners was predominant among respondents belonging to a public institution. A total of 242 (31.96%) of study respondents were aware of the existence of a vaccine for HBV, whereas only 161 (21.2%) had received at least one dose of vaccination against HBV. Previous knowledge of HBV infection, previous HBV testing, and knowing someone who had HBV infection were predictors of HBV infection knowledge as well as vaccination. This study has shown the urgent need for intervention targeted at raising awareness about HBV infection and the existence of a vaccine.

22 November 2008 in Archives of Virology
Verified
Journal Article
Closed access
PDF file
AEAngela Eni
Angela Eni
JHJ. D’a. Hughes
J. D’a. Hughes
RAR. Asiedu
R. Asiedu
MRM. E. C. Rey
M. E. C. Rey

11 February 2010 in Annals of Applied Biology
Verified
Journal Article
Closed access
PDF file
AEAngela Eni
Angela Eni
JHJ.D'A. Hughes
J.D'A. Hughes
RAR. Asiedu
R. Asiedu
MRM.E.C. Rey
M.E.C. Rey

2 October 2008 in Annals of Applied Biology
Verified
Journal Article
Closed access
PDF file
AEAngela Eni
Angela Eni
JHJ.D’a. Hughes
J.D’a. Hughes
MRM.E.C. Rey
M.E.C. Rey

1 August 2018 in Data in Brief
Verified
Journal Article
Open access
AEAngela Eni
Angela Eni
OEOghenevwairhe P. Efekemo
Oghenevwairhe P. Efekemo
MSMojisola G. Soluade
Mojisola G. Soluade
SPSegun Popoola
Segun Popoola
AAAderemi A. Atayero
Aderemi A. Atayero
Cassava mosaic disease (CMD) is one of the most economically important viral diseases of cassava, an important staple food for over 800 million people in the tropics. Although several Cassava mosaic virus species associated with CMD have been isolated and characterized over the years, several new super virulent strains of these viruses have evolved due to genetic recombination between diverse species. In this data article, field survey data collected from 184 cassava farms in 12 South Western and North Central States of Nigeria in 2015 are presented and extensively explored. In each State, one cassava farm was randomly selected as the first farm and subsequent farms were selected at 10 km intervals, except in locations were cassava farms are sporadically located. In each selected farm, 30 cassava plants were sampled along two diagonals and all selected plant was scored for the presence or absence of CMD symptoms. Cassava mosaic disease incidence and associated whitefly vectors in South West and North Central Nigeria are explored using relevant descriptive statistics, box plots, bar charts, line graphs, and pie charts. In addition, correlation analysis, Analysis of Variance (ANOVA), and multiple comparison post-hoc tests are performed to understand the relationship between the numbers of whiteflies counted, uninfected farms, infected farms, and the mean of symptom severity in and across the States under investigation. The data exploration provided in this data article is considered adequate for objective assessment of the incidence and symptom severity of cassava mosaic disease and associated whitefly vectors in farmers' fields in these parts of Nigeria where cassava is heavily cultivated.

19 June 2018 in Journal of Community Health
Verified
Journal Article
Closed access
PDF file
AEAngela Eni
Angela Eni
MSMojisola G. Soluade
Mojisola G. Soluade
OEOghenevwairhe P. Efekemo
Oghenevwairhe P. Efekemo
TITitilayo T. Igwe
Titilayo T. Igwe
Olabode Azeez Onile-ereOlabode Azeez Onile-ere
Olabode Azeez Onile-ere